AI Model for Assessing Cardiac Surgeons' Techniques

Launched by CHINA NATIONAL CENTER FOR CARDIOVASCULAR DISEASES · Dec 13, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how artificial intelligence (AI) can help evaluate the skills of surgeons performing a specific type of heart surgery called coronary artery bypass grafting (CABG). The main focus is to see how well AI scores match up with evaluations made by human experts when looking at how surgeons connect arteries during the surgery. The goal is to improve the quality of surgical techniques and patient outcomes.

To participate in this trial, you need to be at least 18 years old and scheduled to undergo a particular type of bypass surgery using the internal mammary artery. You should be having this surgery for the first time and must be able to provide written consent. However, if you have certain health conditions like acute coronary syndrome or issues with your kidneys or liver, you won't be eligible. If you join, you can expect to help researchers understand the role of AI in assessing surgical skills, which could lead to better heart surgery practices in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Undergoing internal mammary artery-to-left anterior descending artery bypass grafting
• • First-time recipient of isolated CABG surgery
• • Signed written informed consent
• Exclusion Criteria:
• • Patients with acute coronary syndrome
• • Patients with contraindications to coronary CT angiography or coronary angiography
• • Patients with renal insufficiency or active liver disease, including those with persistently elevated serum transaminases of unknown cause or any serum transaminase levels exceeding three times the upper limit of normal.